160 related articles for article (PubMed ID: 9137978)
21. Short-term bioaccumulation of vanadium when ingested with a tea decoction in streptozotocin-induced diabetic rats.
Edel AL; Kopilas M; Clark TA; Aguilar F; Ganguly PK; Heyliger CE; Pierce GN
Metabolism; 2006 Feb; 55(2):263-70. PubMed ID: 16423636
[TBL] [Abstract][Full Text] [Related]
22. Orally active and long-term acting insulin-mimetic vanadyl complex:bis(picolinato)oxovanadium (IV).
Sakurai H; Fujii K; Watanabe H; Tamura H
Biochem Biophys Res Commun; 1995 Sep; 214(3):1095-101. PubMed ID: 7575515
[TBL] [Abstract][Full Text] [Related]
23. Effects of vanadate on in vivo myocardial reactivity to norepinephrine in diabetic rats.
Paulson DJ; Kopp SJ; Tow JP; Peace DG
J Pharmacol Exp Ther; 1987 Feb; 240(2):529-34. PubMed ID: 3543300
[TBL] [Abstract][Full Text] [Related]
24. Insulin-like effects of bis-glycinato oxovanadium (IV) complex on experimental diabetic rats.
Nandhini D; Maneemegalai S; Elangovan V; Sekar N; Govindasamy S
Indian J Biochem Biophys; 1993 Feb; 30(1):73-6. PubMed ID: 8509129
[TBL] [Abstract][Full Text] [Related]
25. Cytoprotective effect of 16,16' dimethyl prostaglandin E2 (dm PGE2) on streptozotocin-induced biochemical alterations of Golgi-rich membrane fraction in comparison with morphology of rat liver Golgi apparatus in situ.
Kordowiak AM
Pathol Res Pract; 1986 Aug; 181(4):397-401. PubMed ID: 2945173
[TBL] [Abstract][Full Text] [Related]
26. Lack of in vivo effect of vanadium on GLUT4 translocation in white adipose tissue of streptozotocin-diabetic rats.
Cam MC; Brownsey RW; Rodrigues B; McNeill JH
Metabolism; 2001 Jun; 50(6):674-80. PubMed ID: 11398144
[TBL] [Abstract][Full Text] [Related]
27. Correction of chronic hyperglycemia with vanadate, but not with phlorizin, normalizes in vivo glycogen repletion and in vitro glycogen synthase activity in diabetic skeletal muscle.
Rossetti L; Lauglin MR
J Clin Invest; 1989 Sep; 84(3):892-9. PubMed ID: 2503545
[TBL] [Abstract][Full Text] [Related]
28. Effects of vanadate on expression of liver arginase in experimental diabetic rats.
Salimuddin ; Upadhyaya KC; Baquer NZ
IUBMB Life; 1999 Aug; 48(2):237-40. PubMed ID: 10794604
[TBL] [Abstract][Full Text] [Related]
29. Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.
Thompson KH; Liboiron BD; Sun Y; Bellman KD; Setyawati IA; Patrick BO; Karunaratne V; Rawji G; Wheeler J; Sutton K; Bhanot S; Cassidy C; McNeill JH; Yuen VG; Orvig C
J Biol Inorg Chem; 2003 Jan; 8(1-2):66-74. PubMed ID: 12459900
[TBL] [Abstract][Full Text] [Related]
30. Glucagon binding and adenylate cyclase activity in liver membranes from untreated and insulin-treated diabetic rats.
Soman V; Felig P
J Clin Invest; 1978 Mar; 61(3):552-60. PubMed ID: 205552
[TBL] [Abstract][Full Text] [Related]
31. Vanadate inhibits glucose output from isolated perfused rat liver.
Bruck R; Prigozin H; Krepel Z; Rotenberg P; Shechter Y; Bar-Meir S
Hepatology; 1991 Sep; 14(3):540-4. PubMed ID: 1874499
[TBL] [Abstract][Full Text] [Related]
32. Aqueous chemistry of the vanadium(III) (V(III)) and the V(III)-dipicolinate systems and a comparison of the effect of three oxidation states of vanadium compounds on diabetic hyperglycemia in rats.
Buglyó P; Crans DC; Nagy EM; Lindo RL; Yang L; Smee JJ; Jin W; Chi LH; Godzala Iii ME; Willsky GR
Inorg Chem; 2005 Jul; 44(15):5416-27. PubMed ID: 16022540
[TBL] [Abstract][Full Text] [Related]
33. Comparison of rat plasma glycoprotein composition with biochemical activity and morphology of liver Golgi apparatus in streptozotocin diabetes treated with insulin.
Kordowiak A; Turyna B; Kaczmarski F; Sarnecka-Keller M
Folia Histochem Cytochem (Krakow); 1981; 19(4):181-8. PubMed ID: 6460671
[TBL] [Abstract][Full Text] [Related]
34. Modulation of mRNA levels of liver arginase by insulin and vanadate in experimental diabetes.
Salimuddin ; Upadhyaya KC; Raju J; Baquer NZ
Indian J Biochem Biophys; 1999 Apr; 36(2):125-8. PubMed ID: 10549172
[TBL] [Abstract][Full Text] [Related]
35. Insulin mimetic role of vanadate on plasma membrane insulin-receptors.
Sekar N; Govindasamy S
Biochem Int; 1991 Feb; 23(3):461-6. PubMed ID: 1877984
[TBL] [Abstract][Full Text] [Related]
36. Modulation of some gluconeogenic enzyme activities in diabetic rat liver and kidney: effect of antidiabetic compounds.
Gupta D; Raju J; Baquer NZ
Indian J Exp Biol; 1999 Feb; 37(2):196-9. PubMed ID: 10641146
[TBL] [Abstract][Full Text] [Related]
37. Long term improvement of glucose homeostasis by vanadate treatment in diabetic rats.
Brichard SM; Okitolonda W; Henquin JC
Endocrinology; 1988 Oct; 123(4):2048-53. PubMed ID: 3046930
[TBL] [Abstract][Full Text] [Related]
38. Insulin-enhancing activity of a dinuclear vanadium complex: 5-chloro-salicylaldhyde ethylenediamine oxovanadium(V) and its permeability and cytotoxicity.
Xie MJ; Yang XD; Liu WP; Yan SP; Meng ZH
J Inorg Biochem; 2010 Aug; 104(8):851-7. PubMed ID: 20434776
[TBL] [Abstract][Full Text] [Related]
39. Insulin-like effect of vanadyl ion on streptozotocin-induced diabetic rats.
Sakurai H; Tsuchiya K; Nukatsuka M; Sofue M; Kawada J
J Endocrinol; 1990 Sep; 126(3):451-9. PubMed ID: 2170556
[TBL] [Abstract][Full Text] [Related]
40. Effect of vanadium compounds on calmodulin activity in experimental diabetes in rats.
Aktan F; Nebioglu S
Can J Physiol Pharmacol; 1994 Jul; 72(7):753-8. PubMed ID: 7828083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
